Thromboxane synthase suppression induces lung cancer cell apoptosis via inhibiting NF-κB

Experimental Cell Research

Volumn 316, Issue 20, 2010, Pages 3468-3477

  Leung, Kin Chung ^a   Li, Ming Yue ^a   Leung, Billy C S ^a   Hsin, Michael K Y ^a   Mok, Tony S K ^a   Underwood, Malcolm J ^a   Chen, George G ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Apoptosis; Lung cancer; Nuclear factor kappaB; Oxidative stress; Thromboxane synthase

Indexed keywords

1 BENZYLIMIDAZOLE; ACETYLCYSTEINE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; REACTIVE OXYGEN METABOLITE; SYNAPTOTAGMIN I; THROMBOXANE SYNTHASE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL DEATH; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME REPRESSION; HUMAN; HUMAN CELL; LUNG CANCER; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT;

EID: 78149415410     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2010.07.003     Document Type: Article

References (40)

1. Miyata A., Yokoyama C., Ihara H., Bandoh S., Takeda O., Takahashi E., Tanabe T. Characterization of the human gene (TBXAS1) encoding thromboxane synthase. Eur. J. Biochem. 1994, 224:273-279.
2. Li X., Tai H.H. Activation of thromboxane A(2) receptors induces orphan nuclear receptor Nurr1 expression and stimulates cell proliferation in human lung cancer cells. Carcinogenesis 2009, 30:1606-1613.
3. Moussa O., Riker J.M., Klein J., Fraig M., Halushka P.V., Watson D.K. Inhibition of thromboxane synthase activity modulates bladder cancer cell responses to chemotherapeutic agents. Oncogene 2008, 27:55-62.
4. Sakai H., Suzuki T., Takahashi Y., Ukai M., Tauchi K., Fujii T., Horikawa N., Minamimura T., Tabuchi Y., Morii M., Tsukada K., Takeguchi N. Upregulation of thromboxane synthase in human colorectal carcinoma and the cancer cell proliferation by thromboxane A2. FEBS Lett. 2006, 580:3368-3374.
5. Wei J., Yan W., Li X., Din Y., Tai H.H. Thromboxane receptor alpha mediates tumor growth and angiogenesis via induction of vascular endothelial growth factor expression in human lung cancer cells. Lung Cancer 2010, 69:26-32.
6. Yoshizato K., Zapf S., Westphal M., Berens M.E., Giese A. Thromboxane synthase inhibitors induce apoptosis in migration-arrested glioma cells. Neurosurgery 2002, 50:343-354.
7. Leung K.C., Hsin M.K., Chan J.S., Yip J.H., Li M., Leung B.C., Mok T.S., Warner T.D., Underwood M.J., Chen G.G. Inhibition of thromboxane synthase induces lung cancer cell death via increasing the nuclear p27. Exp. Cell Res. 2009, 315:2974-2981.
8. Arnaud J., Bost M., Vitoux D., Labarere J., Galan P., Faure H., Hercberg S., Bordet J.C., Roussel A.M., Chappuis P. Societe Francophone d'Etudes et de Recherche sur les Elements Toxiques et Essentiels. Effect of low dose antioxidant vitamin and trace element supplementation on the urinary concentrations of thromboxane and prostacyclin metabolites. J. Am. Coll. Nutr. 2007, 26:405-411.
9. Segal M.L., Fertel R.H., Kraut E.H., Sagone A.L. The role of reactive oxygen species in thromboxane b2 generation by polymorphonuclear leukocytes. J. Lab. Clin. Med. 1983, 102:788-794.
10. Xu S., Jiang B., Maitland K.A., Bayat H., Gu J., Nadler J.L., Corda S., Lavielle G., Verbeuren T.J., Zuccollo A., Cohen R.A. The thromboxane receptor antagonist S18886 attenuates renal oxidant stress and proteinuria in diabetic apolipoprotein E-deficient mice. Diabetes 2006, 55:110-119.
11. Chiu T.L., Su C.C. Tanshinone IIA induces apoptosis in human lung cancer A549 cells through the induction of reactive oxygen species and decreasing the mitochondrial membrane potential. Int. J. Mol. Med. 2010, 25:231-236.
12. Kim K.Y., Ahn J.H., Cheon H.G. Apoptotic action of peroxisome proliferator-activated receptor-gamma activation in human non small-cell lung cancer is mediated via proline oxidase-induced reactive oxygen species formation. Mol. Pharmacol. 2007, 72:674-685.
13. Stachowska E., Dolegowska B., Dziedziejko V., Rybicka M., Kaczmarczyk M., Bober J., Rac M., Machalinski B., Chlubek D. Prostaglandin E2 (PGE2) and thromboxane A2 (TXA2) synthesis is regulated by conjugated linoleic acids (CLA) in human macrophages. J. Physiol. Pharmacol. 2009, 60:77-85.
14. Lin Y., Bai L., Chen W., Xu S. The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy. Expert Opin. Ther. Targets 2010, 14:45-55.
15. Pettigrew L.C., Grotta J.C., Rhoades H.M., Wu K.K. Effect of thromboxane synthase inhibition on eicosanoid levels and blood flow in ischemic rat brain. Stroke 1989, 20:627-632.
16. Li M.Y., Yip J., Hsin M.K., Mok T.S., Wu Y., Underwood M.J., Chen G.G. Haem oxygenase-1 plays a central role in NNK-mediated lung carcinogenesis. Eur. Respir. J. 2008, 32:911-923.
17. Liu Z., Ng E.K., Liang N.C., Deng Y.F., Leung B.C., Chen G.G. Cell death induced by Pteris semipinnata L. is associated with p53 and oxidant stress in gastric cancer cells. FEBS Lett. 2005, 579:1477-1487.
18. Yao Y., Wolverton J.E., Zhang Q., Marathe G.K., Al-Hassani M., Konger R.L., Travers J.B. Ultraviolet B radiation generated platelet-activating factor receptor agonist formation involves EGF-R-mediated reactive oxygen species. J. Immunol. 2009, 182:2842-2848.
19. Voehringer D.W. BCL-2 and glutathione: alterations in cellular redox state that regulate apoptosis sensitivity. Free Radic. Biol. Med. 1999, 27:945-950.
20. Oliver K.M., Garvey J.F., Ng C.T., Veale D.J., Fearon U., Cummins E.P., Taylor C.T. Hypoxia activates NF-κB-dependent gene expression through the canonical signaling pathway. Antioxid. Redox Signal. 2009, 11:2057-2064.
21. Ni J., Takayama K., Inoshima N., Uchino J., Harada A., Minami T., Harada T., Zhou C.C., Nakanishi Y. Gene transfer of inhibitor kappaB in human lung cancer cell line NCI-H460 inhibits tumorigenesis and angiogenesis in vivo. Anticancer Res. 2005, 25:69-77.
22. Fan Y.J., Dutta J., Gupta N., Fan G.F., Gelinas C. Regulation of programmed cell death by NF-kappaB and its role in tumorigenesis and therapy. Adv. Exp. Med. Biol. 2008, 615:223-250.
23. Ju W., Wang X., Shi H.L., Chen W.S., Belinsky S.A., Lin Y.A. Critical role of luteolin-induced reactive oxygen species in blockage of tumor necrosis factor-activated nuclear factor-kappaB pathway and sensitization of apoptosis in lung cancer cells. Mol. Pharmacol. 2007, 71:1381-1388.
24. Hong S., Lee C., Kim S.J. Smad7 sensitizes tumor necrosis factor induced apoptosis through the inhibition of antiapoptotic gene expression by suppressing activation of the nuclear factor-kappaB pathway. Cancer Res. 2007, 67:9577-9583.
25. Sanlioglu A.D., Aydin C., Bozcuk H., Terzioglu E., Sanlioglu S. Fundamental principals of tumor necrosis factor-alpha gene therapy approach and implications for patients with lung carcinoma. Lung Cancer 2004, 44:199-211.
26. Gogvadze V., Zhivotovsky B. Alteration of mitochondrial function and cell sensitization to death. J. Bioenerg. Biomembr. 2007, 39:23-30.
27. Pan M.H., Hsieh M.C., Kuo J.M., Lai C.S., Wu H., Sang S.M., Ho C.T. 6-Shogaol induces apoptosis in human colorectal carcinoma cells via ROS production, caspase activation, GADD 153 expression. Mol. Nutr. Food Res. 2008, 52:527-537.
28. Tsatsanis C., Androulidaki A., Venihaki M., Margioris A.N. Signalling networks regulating cyclooxygenase-2. Int. J. Biochem. Cell Biol. 2006, 38:1654-1661.
29. Denlinger C.E., Keller M.D., Mayo M.W., Broad R.M., Jones D.R. Combined proteasome and histone deacetylase inhibition in non-small cell lung cancer. J. Thorac. Cardiovasc. Surg. 2004, 127:1078-1086.
30. Gadgeel S.M., Ali S., Philip P.A., Wozniak A., Sarkar F.H. Genistein enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitors and inhibits nuclear factor kappa B in nonsmall cell lung cancer cell lines. Cancer 2009, 115:2165-2176.
31. Berger N., Ben Bassat H., Klein B.Y., Laskov R. Cytotoxicity of NF-kappaB inhibitors Bay 11-7085 and caffeic acid phenethyl ester to Ramos and other human B-lymphoma cell lines. Exp. Hematol. 2007, 35:1495-1509.
32. Paranjpe A., Cacalano N.A., Hume W.R., Jewett A. N-acetylcysteine protects dental pulp stromal cells from HEMA-induced apoptosis by inducing differentiation of the cells. Free Radic. Biol. Med. 2007, 43:1394-1408.
33. Altavilla D., Squadrito F., Canale P., Ioculano M., Squadrito G., Campo G.M., Serranò M., Sardella A., Urna G., Spignoli G., Caputi A.P. G 619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, inhibits tumor necrosis factor-alpha biosynthesis. Eur. J. Pharmacol. 1995, 286:31-39.
34. Caughey G.E., Pouliot M., Cleland L.G., James M.J. Regulation of tumor necrosis factor-alpha and IL-1 beta synthesis by thromboxane A2 in nonadherent human monocytes. J. Immunol. 1997, 158:351-358.
35. Chen G.G., Lee T.W., Yip J.H., Xu H., Lee I.K., Mok T.S., Warner T.D., Yim A.P. Increased thromboxane B2 levels are associated with lipid peroxidation and Bcl-2 expression in human lung carcinoma. Cancer Lett. 2006, 234:193-198.
36. Antosiewicz J., Ziolkowski W., Kaczor J.J., Herman-Antosiewicz A. Tumor necrosis factor-alpha-induced reactive oxygen species formation is mediated by JNK1-dependent ferritin degradation and elevation of labile iron pool. Free Radic. Biol. Med. 2007, 43:265-270.
37. Babbar N., Casero R.A. Tumor necrosis factor-alpha increases reactive oxygen species by inducing spermine oxidase in human lung epithelial cells: a potential mechanism for inflammation-induced carcinogenesis. Cancer Res. 2006, 66:11125-11130.
38. Kim J.Y., Lee S., Hwangbo B., Lee C.T., Kim Y.M., Han S.K., Shim Y.S., Yoo NF-kappaB C.G. activation is related to the resistance of lung cancer cells to TNF-alpha-induced apoptosis. Biochem. Biophys. Res. Commun. 2000, 273:140-146.
39. Milligan S.A., Nopajaroonsri C. Inhibition of NF-kappa B with proteasome inhibitors enhances apoptosis in human lung adenocarcinoma cells in vitro. Anticancer Res. 2001, 21:39-44.
40. Dodd S., Dean O., Copolov D.L., Malhi G.S., Berk M. N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility. Expert Opin. Biol. Ther. 2008, 8:1955-1962.